Literature DB >> 28483329

Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details?

Girish S Kulkarni1, Zachary Klaassen2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28483329     DOI： 10.1016/j.eururo.2017.04.028

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.

Authors:  Stephen B Williams; Yong Shan; Usama Jazzar; Hemalkumar B Mehta; Jacques G Baillargeon; Jinhai Huo; Anthony J Senagore; Eduardo Orihuela; Douglas S Tyler; Todd A Swanson; Ashish M Kamat
Journal:  JAMA Surg       Date:  2018-10-01       Impact factor: 14.766

2.  Editorial comment: understanding the cost of bladder preservation in muscle invasive bladder cancer-an evaluation of radical cystectomy versus trimodal therapy costs.

Authors:  Diana E Magee; Girish S Kulkarni
Journal:  Transl Androl Urol       Date:  2019-12

3.  Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis.

Authors:  Junlan Qiu; Haifeng Zhang; Dongkui Xu; Lin Li; Lingkai Xu; Yiqing Jiang; Tao Wen; Shun Lu; Fang Meng; Lin Feng; Xiaochen Shu
Journal:  J Oncol       Date:  2022-05-14       Impact factor: 4.501

4.  Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans.

Authors:  Abhishek Kumar; Daniel R Cherry; Patrick T Courtney; Vinit Nalawade; Nikhil Kotha; Paul J Riviere; Jason Efstathiou; Rana R McKay; A Karim Kader; Brent S Rose; Tyler F Stewart
Journal:  Eur Urol Open Sci       Date:  2021-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.